Related references
Note: Only part of the references are listed.Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma A Network Meta-analysis
Sandro Pasquali et al.
ANNALS OF SURGERY (2017)
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
Jens Hoeppner et al.
BMC CANCER (2016)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome
T. Glatz et al.
EJSO (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
Andrew R. Davies et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2014)
Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus
Fergus Noble et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Reduction in length of stay for patients undergoing oesophageal and gastric resections with implementation of enhanced recovery packages
J. Tang et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2013)
MAGIC in practice: Experience of peri-operative ECF/X chemotherapy in gastro-esophageal adenocarcinomas
A. M. Reece-Smith et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
K. R. Fareed et al.
BRITISH JOURNAL OF CANCER (2010)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy
Khaleel R. Fareed et al.
HISTOPATHOLOGY (2009)
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
William H. Allum et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
